InsiderTrades

Form 4/A for CHE CHEMED CORP

Accepted 2024-12-20 00:00:00 ET · period of report 2024-03-20 · accession 0000950170-24-138847 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMA 2024-12-20 2024-03-20 CHE Judkins Brian C VP, CLO M - OptEx $443.22 +12.0K 12.7K +1,631% +$5.30M
DA 2024-12-20 2024-03-20 CHE Judkins Brian C VP, CLO S - Sale+OE $645.00 -11.2K 1,533 -88% -$7.20M
DMA 2024-12-20 2024-03-20 CHE Judkins Brian C VP, CLO M - OptEx $443.22 -12.0K 29.2K -29% -$5.30M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Capital Stock 2024-03-20 M A 5,825 $413.19 6,558 D — — (F1) Amended filing due to administrative error
2 Common Capital Stock 2024-03-20 M A 6,133 $471.74 12,691 D — —
3 Common Capital Stock 2024-03-20 S D 11,158 $645.00 1,533 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $642.00 to $649.00. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.
4 Derivative Stock Option (right to buy with tandem tax withholding) 2024-03-20 M D 6,133 $471.74 23,050 D $471.74 · — to 2025-10-29 6,133 Capital Stock (F4) Vesting in three equal annual installments commencing 10/29/2021
5 Derivative Stock Option (right to buy with tandem tax withholding) 2024-03-20 M D 5,825 $413.19 29,183 D $413.19 · — to 2024-10-29 5,825 Capital Stock (F3) Vesting in three equal annual installments commencing 10/29/2020